Application of Induced Pluripotent Stem Cells in Moyamoya Disease: Progress and Promises

Author:

Zhao Jizong12345,Xue Yimeng12,Zhang Qian2345,Wang Lin-jian12,Tu Wen-Jun26

Affiliation:

1. Savaid Medical School, University of Chinese Academy of Sciences, Beijing China

2. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

3. Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China

4. Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China

5. China National Clinical Research Center for Neurological Diseases, Beijing, China

6. Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China

Abstract

Abstract: Moyamoya disease (MMD) is a chronic steno-occlusion cerebrovascular disease, accompanied by the formation of abnormal vascular network at the base of brain. The etiology of MMD is not fully clarified. Lack of pathological specimens hinders the research progress. Induced pluripotent stem cell (iPSC) derived from patients with outstanding differentiation potential and infinite proliferation ability could conquer the problem of insufficient sample. The technology of iPSC holds the promise of clarifying the underlying molecular mechanism in the development of MMD. In this review, we summarized latest progresses and difficulties in the research of mechanism, and detailed the application of iPSC in MMD, aiming to provide an outlook of iPSC in molecular mechanism and novel therapies of MMD.

Publisher

Bentham Science Publishers Ltd.

Subject

General Medicine,Medicine (miscellaneous)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3